Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase F1 subunit alpha pseudogene 2 (ATP5F1AP2) is one of several pseudogenes related to the ATP synthase F1 subunit alpha gene (ATP5F1A)[3]. Pseudogenes are non-functional segments of DNA that resemble functional genes but generally do not encode active or functional proteins. The canonical ATP synthase F1 subunit alpha is a key component of mitochondrial Complex V, critical for ATP production via oxidative phosphorylation in mitochondria[1][5][6]. However, as a pseudogene, ATP5F1AP2 lacks protein-coding capacity and does not play a direct role in the enzymatic synthesis of ATP or in any biological process, nor is it a recognized drug or therapeutic target[3]. No evidence was found linking this pseudogene to disease, clinical biomarkers, drugs, or therapeutic mechanisms. There is nothing inherently dysfunctional about ATP5F1AP2 as an entry; however, it is not a protein-coding gene, active receptor, enzyme, or drug target. If you are seeking information on the functional protein, refer to ATP synthase F1 subunit alpha (ATP5F1A)[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase F1 subunit alpha pseudogene 2 (ATP5F1AP2).